FDA Experts Meet Today To Strategize New Plan For More Boosters

After using the pandemic to rig the 2020 presidential election, destroy a booming economy, and mandate experimental gene modification shots that have resulted in an unprecedented number of deaths and injuries, the predator class is gearing up to institute another round of vaccine mandates.

Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee will meet on Wednesday to develop a long-term strategy for COVID boosters to mitigate risks posed by new variants.

The advisory meeting will help develop a “general framework” that will inform when additional Covid-19 booster doses, Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement.

“Now is the time to discuss the need for future boosters as we aim to move forward safely, with COVID-19 becoming a virus-like others such as influenza that we prepare for, protect against, and treat,” Marks noted. “Bringing together our panel of expert scientific external advisors in an open, transparent discussion about booster vaccination is an important step to gain insight, input and expert advice as we begin to formulate the best regulatory strategy to address COVID-19 and virus variants going forward.”

According to the Center for Disease Control, approximately 77 percent of the U.S. population has received at least one dose of the experimental jab and about 45 percent are boosted.

Meanwhile, the CDC’s Vaccine Adverse Events Reporting System confirms the lethality of so-called COVID vaccines. According to VAERS, 472 Americans died after receiving a COVID shot in March.

In 2021, 21,940 vaccine recipients died after the inoculation while 5,046 have died from vaccine injury as of yet in 2022.

While medications including Ivermectin, Budesonide and Hydroxychloroquine effectively treat COVID-19, the bizarre spike in vaccine-related fatalities, strokes, blood clots and myocarditis among the young and healthy warrants more booster shots according to the FDA and CDC.

“Experts on the advisory committee will discuss the viability of an annual COVID vaccine, similar to the flu shot,” Axios reports. “That would require scientific models to predict how COVID will mutate. Regulators would then need to choose which strains a vaccine should target, and a central body like the World Health Organization would need to oversee changes in vaccine composition.”

“Manufacturers would also need considerable lead time to make potentially hundreds of millions of doses of modified vaccine,” the publication notes.

The agenda for Wednesday’s meeting includes the effectiveness of vaccines on children and adults, data showcasing the effects of the fourth dose in Israel and updates from experts on coronavirus variants.

On March 29, Centers for Disease Control and Prevention Director Rochelle Walensky expanded emergency use authorization for a second COVID-19 booster shot to all Americans age 50 or older to get a second booster shot as early as four months after their first booster dose of any Covid-19 vaccine.

Americans should prepare for booster shots to become an annual occurrence akin to flu shots, Dr. Anthony Fauci, chief medical adviser to Joe Biden, said Friday.

“We don’t know this as a fact, but it could be that we may need an intermittent boost on a yearly basis until we get this level so low down,” Fauci told CNN’s Dr. Sanjay Gupta.

COVID-19 vaccines are necessary until coronavirus no longer affects society, the murderous director of the National Institute of Allergy and Infectious Diseases continued.

“We want to get it to such a low level that it does not interfere at all with us, and if that does require a yearly vaccine that might be adjusted to a new variant, just the same way we adjust the influenza vaccines, we’ll just have to wait and see,” Fauci said. “We need to be prepared for that.”